14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $27.14 $33.02 Thursday, 25th Apr 2024 AGIO stock ended at $31.67. During the day the stock fluctuated 3.32% from a day low at $31.22 to a day high of $32.25.
90 days $22.23 $35.48
52 weeks $19.80 $35.48

Historical Agios Pharmaceuticals prices

Date Open High Low Close Volume
Oct 25, 2023 $20.76 $20.88 $19.99 $20.18 500 647
Oct 24, 2023 $20.97 $21.31 $20.83 $20.92 745 904
Oct 23, 2023 $21.15 $21.48 $20.80 $20.96 417 201
Oct 20, 2023 $21.43 $21.68 $21.06 $21.38 654 321
Oct 19, 2023 $21.70 $21.75 $21.09 $21.42 813 290
Oct 18, 2023 $22.41 $22.41 $21.74 $21.81 489 051
Oct 17, 2023 $22.98 $23.36 $22.04 $22.64 451 335
Oct 16, 2023 $23.19 $23.49 $22.62 $23.11 627 384
Oct 13, 2023 $23.07 $23.33 $22.88 $23.12 648 490
Oct 12, 2023 $23.22 $23.26 $22.69 $22.97 474 227
Oct 11, 2023 $23.77 $23.95 $23.27 $23.36 491 790
Oct 10, 2023 $23.99 $24.17 $23.50 $23.77 2 520 421
Oct 09, 2023 $23.81 $24.10 $23.52 $24.01 352 112
Oct 06, 2023 $24.29 $24.40 $23.63 $24.00 434 165
Oct 05, 2023 $23.85 $24.89 $23.67 $24.53 883 206
Oct 04, 2023 $24.07 $24.13 $23.66 $23.98 197 060
Oct 03, 2023 $24.04 $24.35 $23.81 $24.02 187 314
Oct 02, 2023 $24.74 $24.74 $23.84 $24.22 312 765
Sep 29, 2023 $24.97 $25.12 $24.50 $24.75 417 129
Sep 28, 2023 $24.43 $24.79 $24.04 $24.77 212 799
Sep 27, 2023 $24.43 $24.94 $24.30 $24.54 394 993
Sep 26, 2023 $24.41 $25.03 $24.34 $24.36 306 898
Sep 25, 2023 $24.47 $24.79 $24.06 $24.41 271 169
Sep 22, 2023 $24.93 $25.04 $24.40 $24.53 209 694
Sep 21, 2023 $24.37 $25.02 $24.21 $24.90 211 428
Click to get the best stock tips daily for free!

About Agios Pharmaceuticals

Agios Pharmaceuticals Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Ph... AGIO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT